Claim Missing Document
Check
Articles

Found 1 Documents
Search

In Silico Investigation of the Honey Bee-Derived IKKVHR Peptide as a Potential Modulator of Molecular Targets Involved in Diabetic Ulcer Healing: A Network Pharmacology and Molecular Docking Approach Arza, Ikra Alfata; Fortuna, Fortuna; Taufik, Rahmat
Journal La Medihealtico Vol. 7 No. 5 (2026): Journal La Medihealtico
Publisher : Newinera Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37899/journallamedihealtico.v7i5.6018

Abstract

Diabetic ulcers are a major complication of diabetes mellitus characterized by prolonged inflammation, impaired tissue regeneration, and dysregulated extracellular matrix remodeling. Honey-derived bioactive peptides may have therapeutic potential, although their molecular targets and mechanisms remain incompletely understood. This study aimed to evaluate the potential of the IKKVHR peptide as a molecular modulator of diabetic ulcer healing using network pharmacology and molecular docking approaches. This experimental in silico study used the IKKVHR peptide identified from Madu Nusantara® honey through liquid chromatography–high-resolution mass spectrometry (LC-HRMS) as part of an umbrella study. Skin permeability and toxicity were predicted using SwissADME and ProTox 3.0. Peptide and diabetic ulcer targets were analyzed using STRING and Cytoscape, while molecular docking against prioritized target proteins was performed using MOE v2022. IKKVHR showed a log Kp value of −11.88 cm/s, an LD50 of 3000 mg/kg, toxicity class 5, and was predicted to be non-sensitizing to the skin. Network analysis identified 42 overlapping targets, with TNF, IL-1β, STAT3, and MMP3 as hub proteins. Binding affinities toward IL-1β, TNF, MMP3, and STAT3 were −9.16, −9.00, −8.77, and −8.56 kcal/mol, respectively, with all RMSD values <2.5 Å. These findings indicate that IKKVHR may interact with key mediators of inflammation, tissue regeneration, and matrix remodeling in diabetic ulcers, supporting further in vitro and in vivo validation.